Navigation Links
Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
Date:11/7/2007

)

EUFLEXXA(TM) received PMA approval from the U.S. Food and Drug Administration (FDA) on December 3, 2004, and became available to the public on November 8, 2005. For more information, visit http://www.EUFLEXXA.com.

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc., part of the Ferring Group, is a privately owned, international pharmaceutical company. Ferring's line of orthopaedic products includes EUFLEXXA(TM), hyaluronic acid for pain from osteoarthritis in the knee. Urology products include degarelix for prostate cancer (Phase III) and Minirin Melt for bladder dysfunction (Phase III).

Ferring also markets BRAVELLE(R) (urofollitropin for injection, purified), MENOPUR(R) and REPRONEX(R) (menotropins for injection, USP), Novarel(R) (chorionic gonadotropin for injection, USP) and ENDOMETRIN (progesterone) Vaginal Insert, 100 mg in the U.S. to infertility specialists and their patients. Ferring also offers the Q.CAP(TM), the first and only needle-free reconstitution device, for use with its fertility treatments.

Other products include ACTHREL(R) (corticorelin ovine triflutate for injection) for the differential diagnosis of Cushing's syndrome and DESMOPRESSIN ACETATE in injectable and rhinal tube forms for the treatment of diabetes insipidus and primary nocturnal enuresis.

The Ferring Group specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/gynecology and infertility. For more information, call 888-337-7464 or visit http://www.FerringUSA.com.

1 Centers for Disease Control and Prevention. MMWR. 2004;53:388-389,

2 Kirchner M, Marshall D. A double-blind randomized controlled trial

comparing alternate forms of high molecular weight hyaluronan for the

treatment of osteoarthritis of the knee
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... CLARA, Calif. , July 30, 2014 ... economy, released a study today that examines ... biopharma and medical device companies.  According to the annual ... saw the biggest potential returns since SVB started tracking ... year of the IPO.  Built on solid healthcare M&A ...
(Date:7/30/2014)... , July 30, 2014  Lightlake Therapeutics Inc. ... treatments based on its expertise in opioid antagonists, ... commitment from a prominent international research and development ... on promoting innovative research-based initiatives, including those addressing ... spray for the delivery of naloxone that could ...
(Date:7/30/2014)... 2014   Epic Sciences, Inc. ("Epic"), ... develops novel diagnostics to personalize and advance the ... completion of a $30 million Series C Preferred ... (RMI) and Arcus Ventures, existing investors Domain Associates, ... well as undisclosed individual investors. With the proceeds ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3
... Inc. (NYSE: HSP ), a leading global specialty ... will present at the Morgan Stanley Global Healthcare Conference on ... presentation is scheduled to begin at 8:35 a.m. Eastern time ... all interested parties through a live audiocast accessible via the ...
... Wright Therapy Products, Inc. announced today that ... Executive Officer of the company.  The company, based ... devices targeted for the treatment of lymphedema, venous ... Wright Therapy after holding senior financial and sales ...
Cached Medicine Technology:Industry Leaders Hinson and Friel Join Wright Therapy Products 2
(Date:7/30/2014)... Angeles, CA (PRWEB) July 30, 2014 ... the Chao Pinhole Surgical Technique®, the revolutionary minimally invasive ... Dennis Shanelec, considered by many of his peers to ... special guest speaker at a recent Chao Pinhole Surgical ... Alhambra, CA. Dr. Shanelec is the recipient of the ...
(Date:7/30/2014)... DC (PRWEB) July 30, 2014 ... appreciation to U.S. Sens. Thad Cochran (R-MS) and ... for improvements in telemedicine coverage under Medicare, Medicaid ... and Wicker, both Mississippi Republicans, introduced the Telehealth ... to a House version, H.R. 3306, introduced by ...
(Date:7/30/2014)... 2014 The Institute for Integrative Nutrition ... announce that Arianna Huffington has joined as a guest speaker ... Health Coach Training Program . , Arianna Huffington is the ... news and blogging site that won a Pulitzer Prize in ... books and was included on the Forbes “Most Powerful Women” ...
(Date:7/30/2014)... 2014 Frozen shoulder (Adhesive capsulitis) affects 10-20 ... develop this nasty condition which occurs most frequently in people ... up to two and half years if not treated. , ... with good reason: it can render your shoulder so stiff, ... if you aren't in too much pain to get dressed ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 (HealthDay ... the agitation that commonly strikes people with dementia, a new ... found evidence that watering plants, or sitting or strolling in ... The study authors cautioned that the effects of gardens on ... the evidence of a benefit is limited. But experts said ...
Breaking Medicine News(10 mins):Health News:Periodontist Dr. Dennis Shanelec Comments On The Chao Pinhole Surgical Technique® Training Course 2Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Gardens a Center of Calm for People With Dementia 2Health News:Gardens a Center of Calm for People With Dementia 3
... Denver, Colorado (June 1, 2011) Five advocacy organizations ... granted travel awards by the International Association for the ... the 14th World Conference on Lung Cancer, July 3-7 ... Australian Lung Foundation (Australia): The Australian Lung Foundation is ...
... (HealthDay News) -- Age alone should not be the sole determining ... a new study suggests. In following 216 women over the ... if screened properly, people who have facelifts after age 65 are ... , , More than 12 percent of the U.S. ...
... , WEDNESDAY, June 1 (HealthDay News) -- Boys ... significantly higher risk of developing a substance abuse problem ... "Our study, which is one of the largest ... supports the association between ADHD and substance abuse ...
... American Society for Gastrointestinal Endoscopy (ASGE) and the ... updated their 2003 joint guideline for reprocessing gastrointestinal ... account evolved technology and disinfection systems. ... in collaboration with multiple physician and nursing organizations, ...
... anticancer chemotherapeutics. However, it has some severe side effects ... the kidneys. Understanding the mechanisms underlying this toxicity could ... with cisplatin to protect the kidney during chemotherapy. In ... Dong, at Georgia Health Sciences University, Augusta, has now ...
... Dana-Farber Cancer Institute have identified an overactive network ... cells enriched in triple-negative breast tumors, a typically ... therapies. Kornelia Polyak, MD, PhD, a breast ... a large proportion of cells within these tumors ...
Cached Medicine News:Health News:5 advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam 2Health News:5 advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam 3Health News:Plastic Surgery Risks May Depend on More Than Age 2Health News:Children With ADHD More Prone to Substance Abuse: Study 2Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 2Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 3Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 4Health News:Scientists identify overactive genes in aggressive breast cancers 2
... Oxylab pO2 probes feature response ... seconds for real-time monitoring of ... Oxylab LDFTM, measurements of pO2, ... be obtained from the same ...
Spherical Burr for FR030R, 5 mm....
Tungsten Carbide Burr "HM", 0,7 mm, ISO-No. 007....
"Rosen" burr, 0,7 mm, ISO-No. 007....
Medicine Products: